Colon Cancer Survivorship in Patients Who Have Received Adjuvant Chemotherapy

被引:2
|
作者
Kesireddy, Meghana [1 ]
Tenner, Laura [1 ,2 ]
机构
[1] Univ Nebraska, Fred & Pamela Buffett Canc Ctr, Div Hematol Oncol, Med Ctr, Omaha, NE USA
[2] Univ Nebraska, Div Hematol Oncol, Med Ctr, 986840 Nebraska Med Ctr, Omaha, NE 68198 USA
关键词
GI cancer; Long-term side effects; Prevention; INDUCED PERIPHERAL NEUROPATHY; QUALITY-OF-LIFE; CLINICAL-PRACTICE GUIDELINE; OXALIPLATIN-INDUCED NEUROPATHY; PERSONAL FINANCIAL BURDEN; DIETARY GLYCEMIC LOAD; III COLORECTAL-CANCER; BODY-MASS INDEX; CURATIVE RESECTION; PHYSICAL-ACTIVITY;
D O I
10.1016/j.clcc.2023.07.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The number of colon cancer survivors in the United States is increasing due to improved early detection, better treatments that extend survival, and the growing aging population who are at high risk for cancer. Following initial active treatment, colon cancer survivors experience a wide range of long-term physical, psychological, and socio-economic effects that impact their overall well-being. Healthcare providers caring for survivors need to pr ior itize not only monitoring for cancer recurrence but also optimizing their overall health through addressing these long-term effects; managing their comorbidities; promoting healthy behaviors (like exercise, nutrition, and weight loss); and screening for a second primary cancer depending on their risk. Personalized survivorship care plans should be formulated clearly outlining the roles of various healthcare providers involved in their care. Our review article focuses on these various aspects of colon cancer survivorship, including surveillance for cancer recurrence specific to those who received adjuvant chemotherapy with curative intent.
引用
收藏
页码:361 / 374
页数:14
相关论文
共 50 条
  • [31] Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone
    Ivana Sestak
    Miguel Martín
    Peter Dubsky
    Ralf Kronenwett
    Federico Rojo
    Jack Cuzick
    Martin Filipits
    Amparo Ruiz
    William Gradishar
    Hatem Soliman
    Lee Schwartzberg
    Richard Buus
    Dominik Hlauschek
    Alvaro Rodríguez-Lescure
    Michael Gnant
    [J]. Breast Cancer Research and Treatment, 2019, 176 : 377 - 386
  • [32] Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone
    Sestak, Ivana
    Martin, Miguel
    Dubsky, Peter
    Kronenwett, Ralf
    Rojo, Federico
    Cuzick, Jack
    Filipits, Martin
    Ruiz, Amparo
    Gradishar, William
    Soliman, Hatem
    Schwartzberg, Lee
    Buus, Richard
    Hlauschek, Dominik
    Rodriguez-Lescure, Alvaro
    Gnant, Michael
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (02) : 377 - 386
  • [33] Older patients with colon cancer: Is adjuvant chemotherapy safe and effective?
    Arora, A
    Potter, J
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (04) : 567 - 569
  • [34] Use of Adjuvant Chemotherapy After Surgery in Patients With Colon Cancer
    Gordan, Lucio N.
    Diaz, Michael
    [J]. JAMA SURGERY, 2017, 152 (09) : 894 - 895
  • [35] Quality of Life Assesment in Patients With Non-Small Cell Lung Cancer Patients Who Have or Have Not Received Second Line Chemotherapy
    Yalcin, B.
    Suna, N.
    Dogan, M.
    Urun, Y.
    Ozdemir, N.
    Gonullu, U.
    Zengin, N.
    Utkan, G.
    Demirkazik, A.
    Icli, F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S620 - S620
  • [36] Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy
    Kawano, Kouichiro
    Tsuda, Naotake
    Waki, Kayoko
    Matsueda, Satoko
    Hata, Yoshiro
    Ushijima, Kimio
    Itoh, Kyogo
    Yamada, Akira
    Kamura, Toshiharu
    [J]. CANCER SCIENCE, 2015, 106 (09) : 1111 - 1117
  • [37] Adjuvant Chemotherapy for Elderly Patients With Colon Cancer: A Vanishing Paradigm?
    Zaniboni, Alberto
    [J]. CLINICAL COLORECTAL CANCER, 2009, 8 (04) : 192 - 193
  • [38] Impact of timing of adjuvant chemotherapy on prognosis of colon cancer patients
    Elsamany, S.
    Alzahrani, A.
    Alkashif, A.
    Abdelmonem, A.
    Elmorsy, S.
    El Taani, H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S512 - S512
  • [39] Adjuvant Chemotherapy in Elderly Patients with Colon Cancer: A Retrospective Study
    Dupuis, Melissa
    Guay, Laurence
    Therrien, Josiane
    Garant, Marie-Pierre
    Beaudoin, Annie
    Lemay, Frederic
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S176 - S176
  • [40] Docetaxel: Response in patients who have received at least two prior chemotherapy regimes for metastatic breast cancer
    Archer, CD
    Lowdell, C
    Sinnett, HD
    English, J
    Khan, S
    Coombes, RC
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 (06) : 816 - 819